Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company is headquartered in Toronto, Canada.
Frequently asked questions
What sector does Vaxil Bio Ltd (VXL) operate in?
Vaxil Bio Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Vaxil Bio Ltd (VXL) current stock price?
As of the latest data, Vaxil Bio Ltd stock price is CA$0.16, with a previous close of CA$0.18. Vaxil Bio Ltd lost -CA$0.02 in the last trading session, representing a -8.57% loss.
What is Vaxil Bio Ltd (VXL) current market capitalization?
Vaxil Bio Ltd market cap is approximately 637.44 thousand.
What is Vaxil Bio Ltd (VXL) Earnings Per Share (EPS)?
The trailing EPS is CA$0.18.
What is Vaxil Bio Ltd (VXL) Price-to-Earnings (P/E) ratio?
Vaxil Bio Ltd current P/E ratio is 0.89.
Does Vaxil Bio Ltd (VXL) pay dividends?
No. Vaxil Bio Ltd does not pay a dividend.
When is Vaxil Bio Ltd (VXL) next earnings report?
Vaxil Bio Ltd is expected to release its next earnings report on June 30, 2026.
What is Vaxil Bio Ltd (VXL) beta (volatility) score?
Vaxil Bio Ltd has a beta of -0.876, indicating lower volatility than the overall market.